These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 25108226)
1. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina. Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy. Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models. Chen Y; Hu Y; Lin M; Jenkins AJ; Keech AC; Mott R; Lyons TJ; Ma JX Diabetes; 2013 Jan; 62(1):261-72. PubMed ID: 23043158 [TBL] [Abstract][Full Text] [Related]
4. Protective and antioxidant effects of PPARα in the ischemic retina. Moran E; Ding L; Wang Z; Cheng R; Chen Q; Moore R; Takahashi Y; Ma JX Invest Ophthalmol Vis Sci; 2014 May; 55(7):4568-76. PubMed ID: 24825105 [TBL] [Abstract][Full Text] [Related]
5. A Protective Effect of PPARα in Endothelial Progenitor Cells Through Regulating Metabolism. Shao Y; Chen J; Dong LJ; He X; Cheng R; Zhou K; Liu J; Qiu F; Li XR; Ma JX Diabetes; 2019 Nov; 68(11):2131-2142. PubMed ID: 31451517 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of PPARα in retinopathy of type 1 diabetes. Pearsall EA; Cheng R; Matsuzaki S; Zhou K; Ding L; Ahn B; Kinter M; Humphries KM; Quiambao AB; Farjo RA; Ma JX PLoS One; 2019; 14(2):e0208399. PubMed ID: 30716067 [TBL] [Abstract][Full Text] [Related]
7. Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction. Hu Y; Chen Y; Ding L; He X; Takahashi Y; Gao Y; Shen W; Cheng R; Chen Q; Qi X; Boulton ME; Ma JX Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15401-6. PubMed ID: 24003152 [TBL] [Abstract][Full Text] [Related]
8. Activated microglia induce the production of reactive oxygen species and promote apoptosis of co-cultured retinal microvascular pericytes. Ding X; Zhang M; Gu R; Xu G; Wu H Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):777-788. PubMed ID: 28074262 [TBL] [Abstract][Full Text] [Related]
9. Pathogenic Role of Chen Q; Qiu F; Zhou K; Matlock HG; Takahashi Y; Rajala RVS; Yang Y; Moran E; Ma JX Diabetes; 2017 Jun; 66(6):1671-1682. PubMed ID: 28270521 [TBL] [Abstract][Full Text] [Related]
10. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration. Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953 [TBL] [Abstract][Full Text] [Related]
11. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation. Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825 [TBL] [Abstract][Full Text] [Related]
12. Retinal inflammation in murine models of type 1 and type 2 diabetes with diabetic retinopathy. Dharmarajan S; Carrillo C; Qi Z; Wilson JM; Baucum AJ; Sorenson CM; Sheibani N; Belecky-Adams TL Diabetologia; 2023 Nov; 66(11):2170-2185. PubMed ID: 37670018 [TBL] [Abstract][Full Text] [Related]
13. Methylglyoxal induces retinopathy-type lesions in the absence of hyperglycemia: studies in a rat model. Schlotterer A; Kolibabka M; Lin J; Acunman K; Dietrich N; Sticht C; Fleming T; Nawroth P; Hammes HP FASEB J; 2019 Mar; 33(3):4141-4153. PubMed ID: 30485119 [TBL] [Abstract][Full Text] [Related]
15. Salutary effect of fenofibrate on type 1 diabetic retinopathy via inhibiting oxidative stress-mediated Wnt/β-catenin pathway activation. Liu Q; Zhang X; Cheng R; Ma JX; Yi J; Li J Cell Tissue Res; 2019 May; 376(2):165-177. PubMed ID: 30610453 [TBL] [Abstract][Full Text] [Related]
16. Pericyte loss via glutaredoxin2 downregulation aggravates diabetes-induced microvascular dysfunction. Li C; Chen X; Zhang S; Liang C; Deng Q; Li X; Yan H Exp Eye Res; 2024 Oct; 247():110025. PubMed ID: 39117135 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Notch3 Deficiency in Diabetes-Induced Pericyte Loss in the Retina. Liu H; Zhang W; Lilly B J Vasc Res; 2018; 55(5):308-318. PubMed ID: 30347392 [TBL] [Abstract][Full Text] [Related]
18. Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Behl Y; Krothapalli P; Desta T; DiPiazza A; Roy S; Graves DT Am J Pathol; 2008 May; 172(5):1411-8. PubMed ID: 18403591 [TBL] [Abstract][Full Text] [Related]
19. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. Kim J; Kim KM; Kim CS; Sohn E; Lee YM; Jo K; Kim JS Free Radic Biol Med; 2012 Jul; 53(2):357-65. PubMed ID: 22609359 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line. El-Remessy AB; Rajesh M; Mukhopadhyay P; Horváth B; Patel V; Al-Gayyar MM; Pillai BA; Pacher P Diabetologia; 2011 Jun; 54(6):1567-78. PubMed ID: 21373835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]